Artwork

Innhold levert av IDEA Pharma. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av IDEA Pharma eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

The Industrial Revolution of Drug Discovery with Dr. Michael Secora

51:36
 
Del
 

Manage episode 350353215 series 3382232
Innhold levert av IDEA Pharma. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av IDEA Pharma eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the industrial revolution of drug discovery. Michael is a scientist and a former equity investor.

In the episode, Michael delves into the reasons behind the incredibly fast growth at Recursion, the company’s mission of decoding biology to radically improve lives, the relatability of data, and how Recursion builds its various data sets for drug discovery. Moreover, he expounds on how Recursion stands out against its competitors in the tech industry, the unique demographics of the Recursion team, and what differentiates Recursion from other AI discovery companies.

Tune in!

During this episode, you will learn about;

[00:23] Introducing today’s episode

[01:29] About Michael Secora and Recursion as it is today

[04:58] Recursion’s Mission on decoding biology to improve lives radically

[08:48] Biotechnology versus BioPharma Companies

[15:00] Relatability of Data

[17:10] Recursion’s data sets & their contents

[22:13] How many terabytes of data are they in executing each experiment

[24:15] How Recursion stands out against competitors in the Tech environment

[26:23] Michael’s approach to humility in the pharmaceutical industry

[28:28] Demographics of the Recursion team

[31:20] Recursion’s Hack Week

[34:51] The difference between AI discovery companies & Recursion

[40:11] A hint of Recursion incredible speed in delivering value proposition

[47:47] Michael’s Book Recommendations

[50:16] How to connect with Michael & Recursion`

Don’t forget to Follow, Rate, Review, Like, and Share!

Mentioned Books

Let’s Connect!

Follow Recursion on;

Follow Michael Secora

More Products

Follow Mike Rea on;

To listen to more amazing podcast episodes: https://podcast.ideapharma.com/

  continue reading

53 episoder

Artwork
iconDel
 
Manage episode 350353215 series 3382232
Innhold levert av IDEA Pharma. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av IDEA Pharma eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the industrial revolution of drug discovery. Michael is a scientist and a former equity investor.

In the episode, Michael delves into the reasons behind the incredibly fast growth at Recursion, the company’s mission of decoding biology to radically improve lives, the relatability of data, and how Recursion builds its various data sets for drug discovery. Moreover, he expounds on how Recursion stands out against its competitors in the tech industry, the unique demographics of the Recursion team, and what differentiates Recursion from other AI discovery companies.

Tune in!

During this episode, you will learn about;

[00:23] Introducing today’s episode

[01:29] About Michael Secora and Recursion as it is today

[04:58] Recursion’s Mission on decoding biology to improve lives radically

[08:48] Biotechnology versus BioPharma Companies

[15:00] Relatability of Data

[17:10] Recursion’s data sets & their contents

[22:13] How many terabytes of data are they in executing each experiment

[24:15] How Recursion stands out against competitors in the Tech environment

[26:23] Michael’s approach to humility in the pharmaceutical industry

[28:28] Demographics of the Recursion team

[31:20] Recursion’s Hack Week

[34:51] The difference between AI discovery companies & Recursion

[40:11] A hint of Recursion incredible speed in delivering value proposition

[47:47] Michael’s Book Recommendations

[50:16] How to connect with Michael & Recursion`

Don’t forget to Follow, Rate, Review, Like, and Share!

Mentioned Books

Let’s Connect!

Follow Recursion on;

Follow Michael Secora

More Products

Follow Mike Rea on;

To listen to more amazing podcast episodes: https://podcast.ideapharma.com/

  continue reading

53 episoder

Wszystkie odcinki

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett